Meningitis B Vaccine’s High Price Tag Poses a Health Care Conundrum – Los Angeles Times via Kaiser Health News

Read article – Continued coverage of comments by Adrienne Faerber, lecturer at the Dartmouth Institute for Health Policy and Clinical Practice, about the costs of the meningitis B vaccine. “Parents believe their children are susceptible to this terrible condition, and [drugmakers] use that fear to get parents to take action,” says Faerber. (Picked up by STAT.)

Top